Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness

Clinical trial NCT06282315 · RECRUITING

Trial details

NCT number: NCT06282315
Sponsor: Insud Pharma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Soil-Transmitted Helminths

Start date: 2025-09-01
Primary completion: 2026-04-01
Enrollment: 20000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.